Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | GMAB | RGC | ||
| Company | Ascendis Pharma ADR | Genmab A/S ADR | Regencell Bioscience Holdings Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 244.56 | 28.80 | 30.46 | ||
| High | 245.57 | 28.87 | 30.50 | ||
| Low | 241.64 | 28.39 | 28.08 | ||
| Latest | 244.48 | 28.55 | 28.67 | ||
| Change | +1.53 | +0.25 | -1.90 | ||
| % Change | +0.63% | +0.88% | -6.22% | ||
| Volume | 374,400 | 2,194,900 | 152,900 | ||
| 20-Day Average Volume | 540,100 | 1,685,350 | 173,300 | ||
| Previous Close | 242.95 | 28.30 | 30.57 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 230.37 | 27.28 | 28.07 | ||
| 20-Day Raw Stochastic | 83.59% | 80.36% | 33.24% | ||
| 20-Day Relative Strength | 58.29 | 52.94 | 51.59 | ||
| Weighted Alpha | +50.23 | +29.48 | +59.59 | ||
| Today's Opinion | 100% Buy | 24% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 40% Sell | 100% Buy | ||
| Last Month's Opinion | 80% Buy | 40% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.17% since 04/10/26 | +1.06% since 04/10/26 | -0.52% since 04/10/26 | ||
| Low | 236.47 on 04/16/26 | 28.01 on 04/13/26 | 28.08 on 04/17/26 | ||
| High | 250.74 on 04/13/26 | 29.43 on 04/14/26 | 33.50 on 04/14/26 | ||
| 1-Month | |||||
| %Chg | +7.20% since 03/17/26 | +8.31% since 03/17/26 | +24.81% since 03/17/26 | ||
| Low | 212.60 on 03/24/26 | 24.95 on 03/20/26 | 22.63 on 03/18/26 | ||
| High | 250.74 on 04/13/26 | 29.43 on 04/14/26 | 40.00 on 04/01/26 | ||
| 3-Month | |||||
| %Chg | +18.78% since 01/16/26 | -11.47% since 01/16/26 | +4.52% since 01/16/26 | ||
| Low | 200.68 on 01/20/26 | 24.95 on 03/20/26 | 20.00 on 03/09/26 | ||
| High | 250.74 on 04/13/26 | 34.68 on 01/27/26 | 40.00 on 04/01/26 | ||
| 6-Month | |||||
| %Chg | +16.14% since 10/17/25 | -13.93% since 10/17/25 | +64.68% since 10/17/25 | ||
| Low | 186.05 on 10/20/25 | 24.95 on 03/20/26 | 10.33 on 11/25/25 | ||
| High | 250.74 on 04/13/26 | 35.43 on 01/14/26 | 69.00 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 15,249,926 | 18,343,576 | 14,177,000 | ||
| Shares Outstanding, K | 62,377 | 642,507 | 494,489 | ||
| Annual Sales | 814,760,000 | 3,720,000,000 | 0 | ||
| Annual Net Income | -258,000,000 | 963,000,000 | -3,580,000 | ||
| Last Quarter Sales | 279,270,000 | 1,058,000,000 | N/A | ||
| Last Quarter Net Income | -42,910,000 | 31,000,000 | N/A | ||
| 60-Month Beta | 0.49 | 0.97 | 2.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.64 on 02/11/26 | 0.05 on 02/17/26 | N/A | ||
| Latest Earnings Date | 05/07/26 | 05/14/26 | 01/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 02/15/18 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.26 | 0.00 | ||